Fiorella Krapp

22.0k total citations · 1 hit paper
25 papers, 2.1k citations indexed

About

Fiorella Krapp is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Fiorella Krapp has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Epidemiology and 12 papers in Molecular Medicine. Recurrent topics in Fiorella Krapp's work include Antibiotic Resistance in Bacteria (12 papers), Tuberculosis Research and Epidemiology (11 papers) and Pneumonia and Respiratory Infections (7 papers). Fiorella Krapp is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Tuberculosis Research and Epidemiology (11 papers) and Pneumonia and Respiratory Infections (7 papers). Fiorella Krapp collaborates with scholars based in United States, Peru and Canada. Fiorella Krapp's co-authors include Eduardo Gotuzzo, Pamela Nabeta, Jenny Allen, David H. Persing, Roxana Rustomjee, David Alland, Robert Blakemore, Camilla Rodrigues, Doris Hillemann and Mark D. Perkins and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Fiorella Krapp

25 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

2010 1.6k citations Catharina Boehme, Pamela Nabeta et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Fiorella Krapp

Since Specialization

Citations

This map shows the geographic impact of Fiorella Krapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiorella Krapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiorella Krapp more than expected).

Fields of papers citing papers by Fiorella Krapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiorella Krapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiorella Krapp. The network helps show where Fiorella Krapp may publish in the future.

Co-authorship network of co-authors of Fiorella Krapp

This figure shows the co-authorship network connecting the top 25 collaborators of Fiorella Krapp. A scholar is included among the top collaborators of Fiorella Krapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiorella Krapp. Fiorella Krapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibiotic point prevalence survey and antimicrobial resistance in hospitalized patients across Peruvian reference hospitals 2023 ·Journal of Infection and Public Health ·(unknown), Coralith García, Fiorella Krapp, (unknown), Marco Olivera, Víctor Manuel Fernández, Miguel Villegas-Chiroque, (unknown), Martín Casapía, (unknown), Juan Carlos Díaz, (unknown), (unknown), Andrea Farnham, Sarah Tschudin‐Sutter, Esther Kuenzli	4
2	151. Molecular diversity and resistance mechanisms of Klebsiella pneumoniae bloodstream infections in Peru 2022 ·Open Forum Infectious Diseases ·Fiorella Krapp, (unknown), (unknown), Coralith García, (unknown), Theresa J. Ochoa, Jan Jacobs, Omai B. Garner, Victor Nizet, Pablo Tsukayama	1
3	Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates 2022 ·BMC Infectious Diseases ·Travis J. Kochan, Sophia Nozick, (unknown), Bettina H. Cheung, Samuel W. M. Gatesy, (unknown), (unknown), (unknown), Fiorella Krapp, Chao Qi, Egon A. Ozer, Alan R. Hauser	59
4	Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae 2021 ·Antimicrobial Agents and Chemotherapy ·Yanqin Huang, (unknown), (unknown), Nidhi Singh, Jiping Wang, Ke Chen, Yinzhi Lang, Jieqiang Zhou, (unknown), Fiorella Krapp, Egon A. Ozer, Alan R. Hauser, Jian Li, Jürgen B. Bulitta, Zackery P. Bulman	17
5	Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae 2021 ·mSystems ·Zackery P. Bulman, Fiorella Krapp, Nathan B. Pincus, Eric Wenzler, Katherine R. Murphy, Chao Qi, Egon A. Ozer, Alan R. Hauser	32
6	Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae 2021 ·Journal of Antimicrobial Chemotherapy ·Yanqin Huang, (unknown), Eric Wenzler, Egon A. Ozer, Fiorella Krapp, Jürgen B. Bulitta, Alan R. Hauser, Zackery P. Bulman	19
7	Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib 2020 ·Journal of Antimicrobial Chemotherapy ·David A. Butler, (unknown), Fiorella Krapp, Shitalben Patel, Yanqin Huang, Egon A. Ozer, Alan R. Hauser, Zackery P. Bulman	13
8	1189. A Comprehensive Characterization of the Emerging Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates From a Public Hospital in Lima, Peru 2018 ·Open Forum Infectious Diseases ·Fiorella Krapp, (unknown), (unknown), (unknown), (unknown), Maribel Riveros, Coralith García	4
9	Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains from Patients with Necrotizing Skin and Soft Tissue Infections 2017 ·Scientific Reports ·Fiorella Krapp, Andrew R. Morris, Egon A. Ozer, Alan R. Hauser	41
10	Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation 2017 ·International Journal of Antimicrobial Agents ·Fiorella Krapp, Jennifer Grant, Sarah H. Sutton, Egon A. Ozer, (unknown)	39
11	Draft Genome Sequence of a Multidrug-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Isolate from a Clinical Source 2016 ·Genome Announcements ·Egon A. Ozer, Andrew R. Morris, Fiorella Krapp, Christopher S. Henry, Keith E. J. Tyo, Wyndham W. Lathem, Alan R. Hauser	4
12	Public Transportation and Tuberculosis Transmission in a High Incidence Setting 2015 ·PLoS ONE ·Carlos Zamudio, Fiorella Krapp, (unknown), Lena Shah, Antonio Ciampi, Eduardo Gotuzzo, Jody Heymann, Carlos Seas, Timothy F. Brewer	38
13	Geographic predictors of primary multidrug-resistant tuberculosis cases in an endemic area of Lima, Peru 2014 ·The International Journal of Tuberculosis and Lung Disease ·Lisa Shah, (unknown), Lea Berrang‐Ford, Germán Henostroza, Fiorella Krapp, Carlos Zamudio, Jody Heymann, Jay S. Kaufman, Antonio Ciampi, Carlos Seas, Eduardo Gotuzzo, Timothy F. Brewer	16
14	A Bayesian Poisson specification with a conditionally autoregressive prior and a residual Morans coefficient minimization criterion for quantitating leptokurtic distributions in regression-based multi-drug resistant tuberculosis treatment protocols 2013 ·Journal of Public Health and Epidemiology ·Benjamin G. Jacob, Fiorella Krapp, (unknown), Nanhua Zhang, (unknown), (unknown), Daniel A. Griffith, Eduardo Gotuzzo, Robert J. Novak	1
15	Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru 2012 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·(unknown), César Ugarte‐Gil, Carlos Zamudio, Fiorella Krapp, Eduardo Gotuzzo, Carlos Seas	6
16	Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment 2011 ·PLoS ONE ·Timothy F. Brewer, (unknown), Carlos Seas, Fiorella Krapp, Carlos Zamudio, Lena Shah, Antonio Ciampi, Jody Heymann, Eduardo Gotuzzo	16
17	High Prevalence of Primary Multidrug Resistant Tuberculosis in Persons with No Known Risk Factors 2011 ·PLoS ONE ·Larissa Otero, Fiorella Krapp, (unknown), Carlos Zamudio, Francine Matthys, Eduardo Gotuzzo, Patrick Van der Stuyft, Carlos Seas	22
18	Predictors of primary multiple drug resistant tuberculosis (MDR-TB) transmission in Lima, Peru 2010 ·International Journal of Infectious Diseases ·Lisa Shah, (unknown), Fiorella Krapp, Carlos Zamudio, Carlos Seas, Antonio Ciampi, Timothy F. Brewer, Eduardo Gotuzzo	1
19	Accounting for autocorrelation in multi-drug resistant tuberculosis predictors using a set of parsimonious orthogonal eigenvectors aggregated in geographic space 2010 ·Geospatial health ·Benjamin G. Jacob, Fiorella Krapp, (unknown), Eduardo Gotuzzo, Daniel A. Griffith, Robert J. Novak	8
20	Rapid Molecular Detection of Tuberculosis and Rifampin Resistance breakdown → 2010 ·New England Journal of Medicine ·Catharina Boehme, Pamela Nabeta, Doris Hillemann, Mark P. Nicol, Shubhada Shenai, Fiorella Krapp, Jenny Allen, (unknown), Robert Blakemore, Roxana Rustomjee, Ana Milovic, Martin Jones, Sean M. O’Brien, David H. Persing, Sabine Ruesch-Gerdes, Eduardo Gotuzzo, Camilla Rodrigues, David Alland, Mark D. Perkins	1639

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact